221 related articles for article (PubMed ID: 21722364)
1. Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide.
Tourkina E; Bonner M; Oates J; Hofbauer A; Richard M; Znoyko S; Visconti RP; Zhang J; Hatfield CM; Silver RM; Hoffman S
Fibrogenesis Tissue Repair; 2011 Jul; 4(1):15. PubMed ID: 21722364
[TBL] [Abstract][Full Text] [Related]
2. Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung disease.
Reese C; Perry B; Heywood J; Bonner M; Visconti RP; Lee R; Hatfield CM; Silver RM; Hoffman S; Tourkina E
Arthritis Rheumatol; 2014 Jul; 66(7):1909-19. PubMed ID: 24578173
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of cell functions by CSD peptide subdomains.
Reese C; Dyer S; Perry B; Bonner M; Oates J; Hofbauer A; Sessa W; Bernatchez P; Visconti RP; Zhang J; Hatfield CM; Silver RM; Hoffman S; Tourkina E
Respir Res; 2013 Sep; 14(1):90. PubMed ID: 24011378
[TBL] [Abstract][Full Text] [Related]
4. Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1.
Lee R; Reese C; Perry B; Heywood J; Bonner M; Zemskova M; Silver RM; Hoffman S; Tourkina E
Fibrogenesis Tissue Repair; 2015; 8():11. PubMed ID: 26322128
[TBL] [Abstract][Full Text] [Related]
5. Caveolin-1 regulates chemokine receptor 5-mediated contribution of bone marrow-derived cells to dermal fibrosis.
Lee R; Perry B; Heywood J; Reese C; Bonner M; Hatfield CM; Silver RM; Visconti RP; Hoffman S; Tourkina E
Front Pharmacol; 2014; 5():140. PubMed ID: 24966836
[TBL] [Abstract][Full Text] [Related]
6. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis.
Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL
Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424
[TBL] [Abstract][Full Text] [Related]
7. Caveolin-1 regulates leucocyte behaviour in fibrotic lung disease.
Tourkina E; Richard M; Oates J; Hofbauer A; Bonner M; Gööz P; Visconti R; Zhang J; Znoyko S; Hatfield CM; Silver RM; Hoffman S
Ann Rheum Dis; 2010 Jun; 69(6):1220-6. PubMed ID: 20410070
[TBL] [Abstract][Full Text] [Related]
8. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype.
Mathai SK; Gulati M; Peng X; Russell TR; Shaw AC; Rubinowitz AN; Murray LA; Siner JM; Antin-Ozerkis DE; Montgomery RR; Reilkoff RA; Bucala RJ; Herzog EL
Lab Invest; 2010 Jun; 90(6):812-23. PubMed ID: 20404807
[TBL] [Abstract][Full Text] [Related]
9. Fibrocytes in the fibrotic lung: altered phenotype detected by flow cytometry.
Reese C; Lee R; Bonner M; Perry B; Heywood J; Silver RM; Tourkina E; Visconti RP; Hoffman S
Front Pharmacol; 2014; 5():141. PubMed ID: 24999331
[TBL] [Abstract][Full Text] [Related]
10. Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells.
Brunasso AM; Massone C
F1000Res; 2016; 5():. PubMed ID: 27158466
[TBL] [Abstract][Full Text] [Related]
11. Deficient Adipogenesis of Scleroderma Patient and Healthy African American Monocytes.
Lee R; Reese C; Carmen-Lopez G; Perry B; Bonner M; Zemskova M; Wilson CL; Helke KL; Silver RM; Hoffman S; Tourkina E
Front Pharmacol; 2017; 8():174. PubMed ID: 28420992
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of caveolin 1 in patients with systemic sclerosis: crucial role in the pathogenesis of tissue fibrosis.
Del Galdo F; Sotgia F; de Almeida CJ; Jasmin JF; Musick M; Lisanti MP; Jiménez SA
Arthritis Rheum; 2008 Sep; 58(9):2854-65. PubMed ID: 18759267
[TBL] [Abstract][Full Text] [Related]
13. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
[TBL] [Abstract][Full Text] [Related]
14. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.
Just SA; Lindegaard H; Hejbøl EK; Davidsen JR; Bjerring N; Hansen SWK; Schrøder HD; Hansen IMJ; Barington T; Nielsen C
Respir Res; 2017 Jul; 18(1):141. PubMed ID: 28720095
[TBL] [Abstract][Full Text] [Related]
15. Antifibrotic properties of caveolin-1 scaffolding domain in vitro and in vivo.
Tourkina E; Richard M; Gööz P; Bonner M; Pannu J; Harley R; Bernatchez PN; Sessa WC; Silver RM; Hoffman S
Am J Physiol Lung Cell Mol Physiol; 2008 May; 294(5):L843-61. PubMed ID: 18203815
[TBL] [Abstract][Full Text] [Related]
16. Myeloid cell-specific deletion of Capns1 prevents macrophage polarization toward the M1 phenotype and reduces interstitial lung disease in the bleomycin model of systemic sclerosis.
Zhang L; Zheng D; Yan Y; Yu Y; Chen R; Li Z; Greer PA; Peng T; Wang Q
Arthritis Res Ther; 2022 Jun; 24(1):148. PubMed ID: 35729674
[TBL] [Abstract][Full Text] [Related]
17. Circulating fibrocytes as biomarker of prognosis in Hermansky-Pudlak syndrome.
Trimble A; Gochuico BR; Markello TC; Fischer R; Gahl WA; Lee JK; Kim Y; Burdick MD; Strieter RM; Mehrad B
Am J Respir Crit Care Med; 2014 Dec; 190(12):1395-401. PubMed ID: 25347450
[TBL] [Abstract][Full Text] [Related]
18. Nintedanib downregulates the transition of cultured systemic sclerosis fibrocytes into myofibroblasts and their pro-fibrotic activity.
Cutolo M; Gotelli E; Montagna P; Tardito S; Paolino S; Pizzorni C; Sulli A; Smith V; Soldano S
Arthritis Res Ther; 2021 Aug; 23(1):205. PubMed ID: 34344444
[TBL] [Abstract][Full Text] [Related]
19. Elevated Fibronectin Levels in Profibrotic CD14
Rudnik M; Hukara A; Kocherova I; Jordan S; Schniering J; Milleret V; Ehrbar M; Klingel K; Feghali-Bostwick C; Distler O; Błyszczuk P; Kania G
Front Immunol; 2021; 12():642891. PubMed ID: 34504485
[TBL] [Abstract][Full Text] [Related]
20. Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis.
Mehrad B; Burdick MD; Strieter RM
Int J Biochem Cell Biol; 2009; 41(8-9):1708-18. PubMed ID: 19433312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
